Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
about
Pseudomonas cepacia septicemia associated with intravenous therapyIntroduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria.Pseudomonas cepacia colonization and infection in intensive care units.Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability.Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia)In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients.Outbreaks associated with contaminated antiseptics and disinfectants.Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection.Characterization of some groups of gram-negative nonfermentative bacteria by the carbon source alkalinization technique.Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers.Association of Pseudomonas cepacia with chronic granulomatous diseaseFourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride.Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.Rapid method for identification of gram-negative, nonfermentative bacilli.Characterization of EO-1 strains (Pseudomonas kingii) isolated from clinical specimens and the hospital environment.Resistance of Pseudomonas to quaternary ammonium compounds. II. Cross-resistance characteristics of a mutant of Pseudomonas aeruginosa.Organisms encountered in urine cultures over a 10-year period.Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants.Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled waterCauses and prevention of sepsis due to Gram-negative bacteria. Common-source outbreaks.Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsisPseudomonas cepacia septic arthritis due to intra-articular injections of methylprednisolone.Pseudomonas cepacia: the sensitivity of nosocomial strains to new antibiotics.
P2860
Q34585203-62B09676-E9CA-4FF4-94F9-84B7CE41BDE5Q34631478-F12AB619-3AA7-4AF9-9A32-B8136988A40AQ34727350-50C328B8-2C30-4B9F-A2B9-9687C0945955Q35244030-B9A834C9-BD75-4FAB-A444-782D09802AD4Q35632107-37A333BA-59D2-49FB-8B6C-BFD028BC47C7Q35644017-3DF81A31-78E3-4B81-993B-FC3017C4E601Q36957254-2026F9BF-9B39-478A-B400-11CA928375D5Q37146972-BCE1BA35-3FA7-440C-8E60-1973B892C900Q37284312-2A4EAF65-7056-4899-9315-D757D1CF779DQ37342647-80C5DD28-823B-4DAB-A497-FB4FA09CC493Q37361858-52098295-8E19-40EE-BA55-C1B625C923B5Q40077362-BB380FBD-F53C-483C-AF69-5965091B7F35Q40088628-EC7C6BB4-C754-48BC-A0C1-70C6136C2891Q40234801-E9087D52-DA81-4460-A1F3-DF52332F08A1Q40714132-EA18D00E-1E85-4607-902D-DCDC8468D5B6Q40716144-77A92DF5-1604-4A61-A70D-FB017C1657B2Q40730804-2B634C93-5F34-42F6-9A86-19C34F4D0696Q40731334-92535F13-3AEF-4A48-ADB6-C56C7C3B8F99Q40733241-6A9CCDCC-7574-4509-9DF4-5EC13A891BC6Q42051619-A32F883E-EDE3-4107-9AE8-D5977C40F64EQ42565459-AB19F4D5-9EEE-49BF-9F5F-C4EFE9A9042FQ42593224-EC6682F2-DB2B-4039-A02C-42F91EAFFBE9Q54458884-D24C6296-FC4B-41AE-8136-72515B67FD0C
P2860
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@en
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@nl
type
label
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@en
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@nl
prefLabel
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@en
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@nl
P2093
P1476
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.
@en
P2093
P356
10.1056/NEJM197001012820108
P407
P577
1970-01-01T00:00:00Z